Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase 1 3Phase 1/2 1

Status

Completed 73Active not recruiting 20Recruiting 19Unknown 17Terminated 16Not yet recruiting 5Withdrawn 3Suspended 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 128Breast Neoplasms 95Colorectal Neoplasms 62Carcinoma, Hepatocellular 59Stomach Neoplasms 49Squamous Cell Carcinoma of Head and Neck 47Lung Neoplasms 44Prostatic Neoplasms 43Leukemia, Myeloid, Acute 43Triple Negative Breast Neoplasms 42Small Cell Lung Carcinoma 40Uterine Cervical Neoplasms 37Rectal Neoplasms 36Pancreatic Neoplasms 31Neoplasms 29Neoplasm Metastasis 29Recurrence 26Esophageal Squamous Cell Carcinoma 25Ovarian Neoplasms 23Esophageal Neoplasms 23Nasopharyngeal Carcinoma 21Brain Neoplasms 21Lymphoma, Large B-Cell, Diffuse 20Colonic Neoplasms 20Carcinoma, Renal Cell 20Melanoma 19Endometrial Neoplasms 19Biliary Tract Neoplasms 18Head and Neck Neoplasms 17Multiple Myeloma 16

Interventions

irinotecan sucrosofate 1envafolimab 1Vincristine 1Temozolomide 1Neoadjuvant Therapy 1Methotrexate 1Brachytherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Osteosarcoma × Clear all
NCT07560826 2026-05-01

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

Wake Forest University Health Sciences

Phase 2 Not yet recruiting
46 enrolled
Sarcoma

Osteosarcoma

NCT07444918 2026-03-03

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
33 enrolled
Sarcoma

Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT07142863 2025-08-27

Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Not yet recruiting
23 enrolled
Sarcoma

Osteosarcoma

NCT06524778 2024-08-07

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Phase 2 Not yet recruiting
16 enrolled
Sarcoma

Osteosarcoma

NCT06041490 2023-09-18

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Peking Union Medical College Hospital

Phase 2 Not yet recruiting
88 enrolled
GastrointestinalSarcoma

Carcinoma, Hepatocellular, Recurrence, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡